Diabetic retinopathy, superoxide damage and antioxidants

Current Pharmaceutical Biotechnology

Volumn 12, Issue 3, 2011, Pages 352-361

  Santos, Julia M ^a   Mohammad, Ghulam ^a   Zhong, Qing ^a   Kowluru, Renu A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Antioxidants; Apoptosis; Diabetic retinopathy; Metabolic memory; Mitochondria; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ALDEHYDE REDUCTASE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CARNITINE; FRUCTOSE; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOCHONDRIAL DNA; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SELENIUM; SORBITOL; SUPEROXIDE; SUPEROXIDE DISMUTASE; TAURINE; THIAMINE; TROLOX C; UBIDECARENONE;

APOPTOSIS; ARTICLE; BLOOD RETINA BARRIER; CELL LEVEL; CELL VIABILITY; DIABETIC RETINOPATHY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ENZYME ACTIVITY; EPIGENETICS; GLYCEMIC CONTROL; HISTOPATHOLOGY; HUMAN; HYPERGLYCEMIA; MOLECULAR MECHANICS; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PERICYTE; RESPIRATORY CHAIN;

ANTIOXIDANTS; DIABETES MELLITUS; DIABETIC RETINOPATHY; HUMANS; HYPERGLYCEMIA; MITOCHONDRIA; REACTIVE OXYGEN SPECIES; RETINA; SUPEROXIDES; YOUNG ADULT;

EID: 79551656358     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920111794480507     Document Type: Article

References (124)

1. Engerman, R.L.; Kern, T. S. Diabetic retinopathy: is it a consequence of hyperglycemia. Diabet. Med., 1985, 2(3), 200-203.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med., 1993, 329(14), 977-986.
3. Diabetes Control and Complications Trial/Epidemiology of Diabe-tes Interventions and Complications Research Group. Effect of in-tensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 2002, 287(19), 2563-2569.
4. Fowler, M.J. Microvascular and macrovascular complications of diabetes. Clin. Diabetes, 2008, 26(2), 77-82.
5. Porta, M.; Bandello, F. Diabetic retinopathy: A clinical update. Diabetologia, 2002, 45(12), 1617-1634.
6. Frank, R.N. Diabetic retinopathy. N. Engl. J. Med., 2004, 350 (1), 48-58.
7. Kuwabara, T.; Cogan, D.G. Retinal vascular patterns. VI. Mural cells of retinal capillaries. Arch. Ophthalmol., 1963, 69, 492-502.
8. Bresnick, G.H.; Davis, M.D.; Myers, F.L.; de Venecia, G. Clinico-pathologic correlations in diabetic retinopathy. II. Clinical and his-tologic appearances of retinal capillary microaneurysms. Arch. Ophthalmol., 1977, 95 (7), 1215-1220.
9. Engerman, R.L. Pathogenesis of diabetic retinopathy. Diabetes, 1989, 38 (10), 1203-1206.
10. Mizutani, M.; Kern, T.S.; Lorenzi, M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopa-thy. J. Clin. Invest., 1996, 97(12), 2883-2890.
11. Kern, T.S.; Tang, J.; Mizutani, M.; Kowluru, R.; Nagraj, R.; Lorenzi, M. Response of capillary cell death to aminoguanidine predicts the development of retinopathy: Comparison of diabetes and galactosemia. Invest. Ophthalmol. Vis. Sci., 2000, 41(12), 3972-3978.
12. Barber, A.J.; Lieth, E.; Khin, S.A.; Antonetti, D.A.; Buchanan, A.G.; Gardner, T.W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest., 1998, 102(4), 783-791.
13. Raff, M.C.; Barres, B.A.; Burne, J.F.; Coles, H.S.; Ishizaki, Y.; Jacobson, M.D. Programmed cell death and the control of cell survival: lessons from the nervous system. Science, 1993, 262(5134), 695-700.
14. Diabetes Control and Complications Trial Research Group. Early worsening of diabetic retinopathy in the diabetes control and complication trial. Arch. Ophthalmol., 1998, 116(11), 874-886.
15. UKPDS. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet, 1998, 352(9131), 837-853.
16. Engerman, R.L.; Kern, T.S. Progression of incipient diabetic reti-nopathy during good glycemic control. Diabetes, 1987, 36(7), 808-812.
17. Kowluru, R.A. Effect of re-institution of good glycemic control on retinal oxidative stress and nitrative stress in diabetic rats. Diabetes, 2003, 52(3), 818-823.
18. Kowluru, R.A.; Chakrabarti, S.; Chen, S. Re-Institution of good metabolic control in diabetic rats on the activation of caspase-3 and nuclear transcriptional factor (NF-kB) in the retina. Acta Diabetol., 2004, 44(4), 194-199.
19. Kowluru, R.A.; Kanwar, M.; Kennedy, A. Metabolic memory phenomenon and accumulation of peroxynitrite in retinal capillaries. Exp. Diabetes Res., 2007, 2007, 2196.
20. Kowluru, R.A.; Chan, P.S. Metabolic memory in diabetes - from in vitro oddity to in vivo problem: Role of Apoptosis. Brain Res. Bull., 2010, 81(2-3), 297-302.
21. Kanwar, M.; Kowluru, R. Role of glyceraldehyde 3-phosphate dehydrogenase in the development and progression of diabetic reti-nopathy. Diabetes, 2009, 58(1), 227-234.
22. Madsen-Bouterse, S.A.; Mohammad, G.; Kanwar, M.; Kowluru, R.A. Role of mitochondrial DNA damage in the development of diabetic retinopathy, and the metabolic memory phenomenon associated with its progression. Antioxid. Redox Signal., 2010, 13(6), 797-805.
23. Kowluru, R.; Kern, T.S.; Engerman, R.L. Abnormalities of retinal metabolism in diabetes or galactosemia II. Comparison of gamma-glutamyl transpeptidase in retina and cerebral cortex, and effects of antioxidant therapy. Curr. Eye Res., 1994, 13 (12), 891-896.
24. Kowluru, R.A.; Jirousek, M.R.; Stramm, L.E.; Farid, N.A.; Enger-man, R.L.; Kern, T.S. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. V. Relationship between protein kinase C and ATPases. Diabetes, 1998, 47(3), 464-469.
25. Kowluru, R.A.; Tang, J.; Kern, T.S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes, 2001, 50(8), 1938-1942.
26. Oates, P.J.; Mylari, B.L. Aldose reductase inhibitors: therapeutic implications for diabetic complications. Expert. Opin. Investig. Drugs, 1999, 8(12), 2095-2119.
27. Lorenzi, M. The polyol pathway as a mechanism for diabetic retinopathy: attractive, elusive, and resilient. Exp. Diabetes Res., 2007, 2007, 61038.
28. Stitt, A.W. The role of advanced glycation in the pathogenesis of diabetic retinopathy. Exp. Mol. Pathol., 2003, 75(1), 95-108.
29. Stitt, A.W.; Hughes, S.J.; Canning, P.; Lynch, O.; Cox, O.; Frizzell, N.; Thorpe, S. R.; Cotter, T.G.; Curtis, T.M.; Gardiner, T.A. Substrates modified by advanced glycation end-products cause dysfunction and death in retinal pericytes by reducing survival signals mediated by platelet-derived growth factor. Diabetologia, 2004, 47(10), 1735-1746.
30. Ishii, H.; Jirousek, M.R.; Koya, D.; Takagi, C; Xia, P.; Clermont, A.; Bursell, S.E.; Kern, T.S.; Ballas, L.M.; Heath, W.F.; Stramm, L.E.; Feener, E.P.; King, G.L. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC (3 inhibitor. Science, 1996, 272(5262), 728-731.
31. Geraldes, P.; King, G.L. Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res., 2010, 106 (8), 1319-1331.
32. Roy, S.; Lorenzi, M. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats. Diabetologia, 1996, 39(6), 735-738.
33. Kowluru, R.A.; Abbas, S.N. Diabetes-induced mitochondrial dysfunction in the retina. Invest. Ophthalmol. Vis. Sci., 2003, 44(12), 5327-5334.
34. Kowluru, R.A.; Atasi, L.; Ho, Y.S. Role of mitochondrial superoxide dismutase in the development of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2006, 47(4), 1594-1599.
35. Kanwar, M.; Chan, P.S.; Kern, T.S.; Kowluru, R.A. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest. Ophthalmol. Vis. Sci., 2007, 48(8), 3805-3811.
36. Al-Shabrawey, M.; Rojas, M.; Sanders, T.; Behzadian, A.; El-Remessy, A.; Bartoli, M.; Parpia, A.K.; Liou, G.; Caldwell, R.B. Role of NADPH oxidase in retinal vascular inflammation. Invest. Ophthalmol. Vis. Sci., 2008, 49(7), 3239-3244.
37. Madsen-Bouterse, S.; Zhong, Q.; Mohammad, G.; Ho, Y.S.; Kowluru, R.A. Oxidative damage of mitochondrial DNA in diabetes, and its protection by manganese superoxide dismutase. Free Radic. Res., 2010, 44(3), 313-321.
38. Baynes, J.W.; Thrope, S.R. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes, 1999, 48(1), 1-9.
39. Li, W.; Yanoff, M.; Jian, B.; He, Z. Altered mRNA levels of antioxidant enzymes in pre-apoptotic pericytes from human diabetic retinas. Cell Mol. Biol., 1999, 45(1), 59-66.
40. Circu, M.L.; Aw, T.Y. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med., 2010, 48(6), 749-762.
41. Hamada, Y.; Fujii, H.; Fukagawa, M. Role of oxidative stress in diabetic bone disorder. Bone, 2009, 45(1), S35-S38.
42. Naruse, K.; Nakamura, J.; Hamada, Y.; Nakayama, M.; Chaya, S.; Komori, T.; Kato, K.; Kasuya, Y.; Miwa, K.; Hotta, N. Aldose reductase inhibition prevents glucose-induced apoptosis in cultured bovine retinal microvascular pericytes. Exp. Eye Res., 2000, 71(3), 309-315.
43. Miwa, K.; Nakamura, J.; Hamada, Y.; Naruse, K.; Nakashima, E.; Kato, K.; Kasuya, Y.; Yasuda, Y.; Kamiya, H.; Hotta, N. The role of polyol pathway in glucose-induced apoptosis of cultured retinal pericytes. Diabetes Res. Clin. Pract., 2003, 60(1), 1-9.
44. Yang, J.; Lane, P.H.; Pollock, J.S.; Carmines, P.K. Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb. Hypertension, 2010, 55(2), 468-473.
45. Sun, W.; Oates, P.J.; Coutcher, J.B.; Gerhardinger, C; Lorenzi, M.A. A selective aldose reductase inhibitor of a new structural class prevents or reverses early retinal abnormalities in experimental diabetic retinopathy. Diabetes, 2006, 55(10), 2757-2762.
46. Xia, P.; Inoguchi, T.; Kern, T.S.; Engerman, R.L; Oates, P.J.; King, G.L. Characterization of the mechanism for the chronic activation of DAG-PKC pathway in diabetes and hypergalactosemia. Diabetes, 1994, 43(9), 1122-1129.
47. Aiello, L.P.; Brusell, S.E.; Clermont, A.; Duh, E.; Ishii, H.; Takagi, C.; Mori, F.; Ciulla, T.A.; Ways, K.; Jirousek, M.; Smith, L.E.; King, G.L. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta isoform-selective inhibitor. Diabetes, 1997, 46(9), 1473-1480.
48. Park, J.Y.; Takahara, N.; Gabriele, A.; Chou, E.; Naruse, K.; Su-zuma, K; Yamauchi, T.; Ha, S.W.; Meier, M.; Rhodes, C.J.; King, G.L. Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation. Diabetes, 2000, 49(7), 1239-1248.
49. Yokota, T.; Ma, R.C.; Park, J-Y.; Isshiki, K.; Sotiropoulos, K.B.; Rauniyar, R.K.; Bornfeldt, K.E.; King, G.L. Role of protein kinase C on the expression of platelet-derived growth factor and endo-thelin-1 in the retina of diabetic rats and cultured retinal capillary pericytes. Diabetes, 2003, 52(3), 838-845.
50. Kowluru, R.A. Diabetes-induced elevations in retinal oxidative stress, protein kinase C and nitric oxide are inter-related. Acta Dia-betol., 2001, 38(4), 179-185.
51. Green, D.R.; Amarante-Mendes, G.P. The point of no return: mitochondria, caspases, and the commitment to cell death. Results Probl. Cell. Differ., 1998, 24, 45-61.
52. Muller, F.L.; Liu, Y.; Van Remmen, H. Complex III releases su-peroxide to both sides of the inner mitochondrial membrane. J. Biol. Chem., 2004, 279(47), 49064-49073.
53. Van Houten, B.; Woshner, V.; Santos, J.H. Role of mitochondrial DNA in toxic responses to oxidative stress. DNA Repair, 2005, 5(2), 145-152.
54. Stuart, J.A.; Brown, M.F. Mitochondrial DNA maintenance and bioenergetics. Biochim. Biophys. Acta, 2006, 1757(2), 79-89.
55. Radi, R.; Cassina, A.; Hodara, R. Nitric oxide and peroxynitrite interactions with mitochondria. Biol. Chem., 2002, 383(3-4), 401-409.
56. Schreiber, V.; Dantzer, F.; Ame, J.C.; de Murcia, G. Poly(ADP-ribose): novel functions for an old molecule. Nat. Rev. Mol. Cell Biol., 2006, 7(7), 517-528.
57. Pacher, P.; Beckman, J.S.; Liaudet, L. Nitric oxide and peroxyni-trite in health and disease. Physiol. Rev., 2007, 87(1), 315-424.
58. Kowluru, R.A.; Kern, T.S.; Engerman, R.L. Abnormalities of retinal metabolism in diabetes or experimental galactosemia. IV. Anti-oxidant defense system. Free Radic. Biol. Med., 1997, 22(4), 587-592.
59. Du, Y.; Miller, C.M.; Kern, T.S. Hyperglycemia increases mito-chondrial superoxide in retina and retinal cells. Free Radic. Biol. Med., 2003, 35(11), 1491-1499.
60. Kowluru, R.A.; Koppolu, P.; Chakrabarti, S.; Chen, S. Diabetes-induced activation of nuclear transcriptional factor in the retina, and its inhibition by antioxidants. Free Radic. Res., 2003, 37(11), 1169-1180.
61. Kowluru, R.A.; Odenbach, S. Effect of long-term administration of alpha lipoic acid on retinal capillary cell death and the development of retinopathy in diabetic rats. Diabetes, 2004, 53(12), 3233-3238.
62. Kowluru, R.A. Diabetic retinopathy: Mitochondrial dysfunction and retinal capillary cell death. Antioxid. Redox Signal., 2005, 7(11-12), 1581-1587.
63. Kowluru, R.A.; Kowluru, V.; Ho, Y.S.; Xiong, Y. Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic. Biol. Med., 2006, 41(8), 1191-1196.
64. Kowluru, R. A.; Kanwar, M. Oxidative stress and the development of diabetic retinopathy: Contributory role of matrix metalloprotein-ase-2. Free Radic. Biol. Med., 2009, 46(12), 1677-1685.
65. Mohammad, G.; Kowluru, R.A. Matrix metalloproteinase-2 in the development of diabetic retinopathy and mitochondrial dysfunction. Lab. Invest., 2010, In Press.
66. Kowluru, R.A.; Kanwar, M.; Chan, P.S.; Zhang, J.P. Inhibition of retinopathy and retinal metabolic abnormalities in diabetic rats with AREDS-based micronutrients. Arch. Ophthalmol., 2008, 126(9), 1266-1272.
67. Perrone, L.; Devi, T.S.; Hosoya, K.I.; Terasaki, T.; Singh, L.P. Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J. Cell. Physiol., 2009, 221(1), 262-272.
68. Beckman, K.B.; Ames, B.N. The free radical theory of aging matures. Physiol. Rev., 1998, 78(2), 547-581.
69. Li, J.; Wang, J.J.; Yu, Q.; Chen, K.; Mahadev, K.; Zhang, S.X. Inhibition of reactive oxygen species by lovastatin down-regulates EGF expression and ameliorates blood-retinal barrier breakdown in db/db mice: role of NADPH oxidase 4. Diabetes, 2010, 59(6), 1528-1538.
70. Caldwell, R.B.; Zhang, W.; Romero, M.J.; Caldwell, R.W. Vascular dysfunction in retinopathy-an emerging role for arginase. Brain Res. Bull., 2010, 81(2-3), 303-309.
71. Miao L.; St Clair, D.K. Regulation of superoxide dismutase genes: implications in disease. Free Radic. Biol. Med., 2009, 47(5), 344-356.
72. Guo, Z.; Boekhoudt, G.H.; Boss, J.M. Role of the intronic enhancer in tumor necrosis factor-mediated induction of manganous super-oxide dismutase. J. Biol. Chem., 2003, 278(26), 23570-23578.
73. Romeo, G.; Liu, W.H.; Asnaghi, V.; Kern, T.S.; Lorenzi, M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes, 2002, 51(7), 2241-2248.
74. Fuchs, J.; Demidov, D.; Houben, A.; Schubert, I. Chromosomal histone modification patterns--from conservation to diversity. Trends. Plant. Sci., 2006, 11(4), 199-208.
75. Muscoli, C.; Mollace, V.; Wheatley, J.; Masini, E.; Ndengele, M.; Wang, Z.Q.; Salvemini, D. Superoxide-mediated nitration of spinal manganese superoxide dismutase: a novel pathway in N-methyl-D-aspartate-mediated hyperalgesia. Pain, 2004, 111(1-2), 96-103.
76. Rosenblum, J.S.; Gilula, N.B.; Lerner, R.A. On signal sequence polymorphisms and diseases of distribution. Proc. Natl. Acad. Sci. USA, 1996, 93(9), 4471-4473.
77. Sutton, A.; Khoury, H.; Prip-Buus, C.; Cepanec, C.; Pessayre, D.; Degoul, F. The Ala16Val genetic dimorphism modulates the import of human manganese superoxide dismutase into rat liver mitochondria. Pharmacogenetics, 2003, 13(3), 145-157.
78. Hovnik, T.; Dolzan, V.; Bratina, N.U.; Podkrajsek, K.T.; Battelino, T. Genetic polymorphisms in genes encoding antioxidant enzymes are associated with diabetic retinopathy in type 1 diabetes. Diabetes Care, 2009, 32(12), 2258-2262.
79. Petrovic, M.G.; Cilensek, I.; Petrovic, D. Manganese superoxide dismutase gene polymorphism (V16A) is associated with diabetic retinopathy in Slovene (Caucasians) type 2 diabetes patients. Dis. Markers., 2008, 24(1), 59-64.
80. Chen, X.J.; Butow, R.A. The organization and inheritance of the mitochondrial genome. Nat. Rev. Gene, 2008, 6(11), 815-825.
81. Kucej, M.; Kucejova, B.; Subramanian, R.; Chen, X.J.; A. BR. Mitochondrial nucleoids undergo remodeling in response to metabolic cues. J. Cell Sci., 2008, 121 (Pt 11), 1861-1868.
82. Wanrooij, S.; Falkenberg, M. The human mitochondrial replication fork in health and disease. Biochim. Biophys. Acta, 2010, 1797(8), 1378-1388.
83. Johannsen, D.L.; Ravussin, E. The role of mitochondria in health and disease. Curr. Opin. Pharmacol., 2009, 9(6), 780-786.
84. Scarpulla, R.C. Nuclear control of respiratory chain expression by nuclear respiratory factors and PGC-1-related coactivator. Ann. NY. Acad. Sci., 2008, 1147, 321-334.
85. Yin, W.; Signore, A.P.; Iwai, M.; Cao, G.; Gao, Y.; Chen, J. Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury. Stroke, 2008, 39(11), 3057-3063.
86. Bugger, H.; Chen, D.; Riehle, C. Soto, J.; Theobald, H.A.; Hu, X.X.; Ganesan, B; Weimer, B.C.; Abel, E.D. Tissue-specific remodeling of the mitochondrial proteome in type 1 diabetic akita mice. Diabetes, 2009, 58(9), 1986-1997.
87. Kowluru, R.A.; Menon, B.; Gierhart, D. Beneficial effect of zeax-anthin on retinal metabolic abnormalities in diabetic rat. Invest. Ophthalmol. Vis. Sci., 2008, 49(4), 1645-1651.
88. Nishikawa, T.; Edelstein, D.; Brownlee, M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int., Suppl., 2000, 77, S26-S30.
89. Brownlee, M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 2005, 54(6), 1615-1625.
90. Madsen-Bouterse, S.; Mohammad, G.; Kowluru, R.A. Glyceralde-hyde 3 phosphate dehydrogenase in retinal microvasculature: Implications for the development and progression of diabetic retinopa-thy. Invest. Ophthalmol. Vis. Sci., 2010, 51(3), 1765-1772.
91. Liu, C.Y.; Lee, C.F.; Wei, Y.H. Role of reactive oxygen species-elicited apoptosis in the pathophysiology of mitochondrial and neu-rodegenerative diseases associated with mitochondrial DNA mutations. J. Formos. Med. Assoc., 2009, 108(8), 599-611.
92. Anuradha, C.D.; Kanno, S.; Hirano, S. Oxidative damage to mitochondria is a preliminary step to caspase-3 activation in fluoride-induced apoptosis in HL-60 cells. Free Radic. Biol. Med., 2001, 31(3), 367-373.
93. Karpinich, N.O.; Tafani, M.; Rothman, R.J.; Russo, M.A.; Farber, J.L. The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c. J. Biol. Chem., 2002, 277(19), 16547-16562.
94. Armstrong, J.S.; Mitochondria: a target for cancer therapy. Br. J. Pharmacol., 2006, 147(3), 239-248.
95. Mizutani, M.; Gerhardinger, C.; Lorenzi, M. Muller cell changes in human diabetic retinopathy. Diabetes, 1998, 47(3), 455-459.
96. Lee, K.W.; Kim, M.S.; Kang, N.J.; Kim, D.H.; Surh, Y.J.; Lee, H.J.; Moon, A. H-Ras selectively up-regulates MMP-9 and COX-2 through activation of ERK1/2 and NF-kappaB: an implication for invasive phenotype in rat liver epithelial cells. Int. J. Cancer, 2006, 119(8), 1767-1775.
97. Kowluru, R.A. Role of matrix metalloproteinase-9 in the development of diabetic retinopathy and its regulation by H-Ras. Invest. Ophthalmol. Vis. Sci., 2010, 51(8), 4320-4326.
98. Cuda, G.; Paterno, R.; Ceravolo, R.; Candigliota, M.; Perrotti, N.; Perticone, F.; Faniello, M.C.; Schepis, F.; Ruocco, A.; Mele, E.; Cassano, S.; Bifulco, M.; Santillo, M.; Avvedimento, E.V. Protection of human endothelial cells from oxidative stress: role of Ras-ERK1/2 signaling. Circulation, 2002, 105(8), 968-974.
99. Raepple, D.; von Lintig. F.; Zemojtel, T.; Duchniewicz, M.; Jung, A.; Lübbert, M.; Boss, G.R.; Scheele, J.S. Determination of Ras-GTP and Ras GDP in patients with acute myelogenous leukemia (AML), myeloproliferative syndrome (MPS), juvenile myelomono-cytic leukemia (JMML), acute lymphocytic leukemia (ALL), and malignant lymphoma: assessment of mutational and indirect activation. Ann. Hematol., 2009, 88(4), 319-324.
100. Chardin, P.; Camonis, J.H.; Gale, N.W.; van Aelst, L.; Schless-inger, J.; Wigler, M.H.; Bar-Sagi, D. Human Sos1: a guanine nu-cleotide exchange factor for Ras that binds to GRB2. Science, 1993, 260(5112), 1338-1343.
101. Irani, K.; Xia, Y.; Zweier, J.L. Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts. Science, 1997, 275(5306), 1649-1652.
102. Allen, R.G.; Maria, T. Oxidative stress and gene regulation. Free Radic. Biol. Med., 2000, 28(3), 463-499.
103. Kowluru, R.A.; Kanwar, M. Translocation of H-Ras and its implications in the development of diabetic retinopathy. Biochem. Bio-phys. Res. Commun., 2009, 387(3), 461-476.
104. Roth, S.; Shaikh, A.R.; Hennelly, M.M.; Li, Q.; Bindokas, V.; Graham, C.E. Mitogen-activated protein kinases and retinal ischemia. Invest. Ophthalmol. Vis. Sci., 2003, 44(12), 5383-5395.
105. Kern, T.S.; Du, Y.; Miller, C.M.; Hatala, D.A.; Levin, L.A. Over-expression of Bcl-2 in vascular endothelium inhibits the microvas-cular lesions of diabetic retinopathy. Am. J. Pathol., 2010, 176(5), 2550-2558.
106. Suen, D.F.; Norris, K.L.; Youle, R.J. Mitochondrial dynamics and apoptosis. Genes Dev., 2008, 22(12), 1577-1590.
107. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N. Engl. J. Med., 2000, 342(18), 381-389.
108. Hammes, H-P.; Klinzing, I.; Wiegand, S.; Bretzel, R.G.; Cohen, A.M.; Federlin, K. Islet transplantation inhibits diabetic retinopathy in the sucrose-fed diabetic Cohen diabetic rat. Invest. Ophthalmol. Vis. Sci., 1993, 34(6), 2092-2096.
109. Kowluru, R.A.; Zhong, Q.; Kanwar, M. Metabolic memory and diabetic retinopathy: role of inflammatory mediators in retinal peri-cytes. Exp. Eye Res., 2010, 90(5), 617-623.
110. Jezek, P.; Hlavata, L. Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism. Int. J. Biochem. Cell Biol., 2005, 37(12), 2478-2503.
111. Berkowitz, B.A.; Roberts, R.; Stemmler, A.; Luan, H.; Gradianu, M. Impaired apparent ion demand in experimental diabetic reti-nopathy: correction by lipoic Acid. Invest. Ophthalmol. Vis. Sci., 2007, 48(10), 4753-4758.
112. Age Related Eye Disease Study Research Group. The relationship of dietary lipid intake and age-related macular degeneration in a case-control study: AREDS. Report No. 20. Arch. Ophthalmol., 2007, 125(5), 671-679.
113. Vincent, A.M.; Russell, J.W.; Low, P. Feldman, E.L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr. Rev., 2004, 25(4), 612-628.
114. Guerrero-Romero, F.; Rodríguez-Morán, M. Complementary therapies for diabetes: the case for chromium, magnesium, and an-tioxidants. Arch. Med. Res., 2005, 36(3), 250-257.
115. Hammes, H.P.; Du, X.; Edelstein, D.; Taguchi, T.; Matsumura, T.; Ju, Q.; Lin J.; Bierhaus A.; Nawroth, P,; Hannak, D.; Neumaier, M.; Bergfeld, R.; Giardino, I.; Brownlee, M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat. Med., 2003, 9(3), 294-299.
116. Berrone, E.; Beltramo, E.; Solimine, C.; Ape, A.U.; Porta, M. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J. Biol. Chem., 2006, 281(14), 9307-9313.
117. Hao, J.; Shen, W.; Tian, C.; Liu, Z.; Ren, J.; Luo, C.; Long, J.; Sharman, E.; Liu, J. Mitochondrial nutrients improve immune dysfunction in the type 2 diabetic Goto-Kakizaki rats. J. Cell. Mol. Med., 2009, 13(4), 701-711.
118. Pescosolido, N.; Imperatrice, B.; Karavitis, P. Ocular disorders secondary to systemic disease and the potential role of carnitines. Drugs R D, 2008, 1, 15-22.
119. Parvez, S.; Tabassum, H.; Banerjee, B.D.; Raisuddin, S. Taurine prevents tamoxifen-induced mitochondrial oxidative damage in mice. Basic. Clin. Pharmacol. Toxicol., 2008, 102(4), 382-387.
120. Yong-Kee, C.J.; Salomonczyk, D.; Nash, J.E. Development and validation of a screening assay for the evaluation of putative neuro-protective agents in the treatment of parkinson's disease. Neurotox Res., 2010, [Epub ahead of print].
121. Hamilton, S.J.; Chew, G.T.; Watts, G.F. Coenzyme Q10 improves endothelial dysfunction in statin-treated type 2 diabetic patients. Diabetes Care, 2009, 32(5), 810-812.
122. Adlam, V.J.; Harrison, J.C.; Porteous, C.M.; James, A.M.; Smith, R.A.; Murphy, M.P.; Sammut, I.A. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J., 2005, 19(9), 1088-1095.
123. Sheu, S.S.; Nauduri, D.; Anders, M.W. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim. Biophys. Acta., 2006, 1762(2), 256-265.
124. Borisenko, G.G.; Martin, I.; Zhao, Q.; Amoscato, A.A.; Tyurina, Y.Y.; Kagan, V.E. Glutathione propagates oxidative stress triggered by myeloperoxidase in HL-60 cells. Evidence for glu-tathionyl radical-induced peroxidation of phospholipids and cyto-toxicity. J. Biol. Chem., 2004, 279(22), 23453-23462.